SKBA Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Hold
5,019
0.15% 57
2025
Q4
$1.15M Hold
5,019
0.16% 60
2025
Q3
$1.16M Hold
5,019
0.16% 61
2025
Q2
$932K Hold
5,019
0.13% 61
2025
Q1
$1.05M Hold
5,019
0.16% 63
2024
Q4
$892K Sell
5,019
-500
-9% -$91.9K 0.14% 60
2024
Q3
$1.09M Sell
5,519
-50
-0.9% -$9.33K 0.16% 59
2024
Q2
$955K Sell
5,569
-355
-6% -$58.8K 0.15% 59
2024
Q1
$1.08M Hold
5,924
0.17% 56
2023
Q4
$918K Sell
5,924
-30,400
-84% -$4.43M 0.15% 55
2023
Q3
$5.41M Hold
36,324
1% 44
2023
Q2
$4.89M Sell
36,324
-5,119
-12% -$751K 0.88% 52
2023
Q1
$6.6M Sell
41,443
-44,000
-51% -$6.73M 1.23% 44
2022
Q4
$13.8M Sell
85,443
-230
-0.3% -$35.3K 2.55% 9
2022
Q3
$11.5M Sell
85,673
-10,735
-11% -$1.54M 2.44% 11
2022
Q2
$14.8M Sell
96,408
-13,550
-12% -$2.07M 2.95% 5
2022
Q1
$17.8M Sell
109,958
-24,800
-18% -$3.6M 3.22% 3
2021
Q4
$18.2M Sell
134,758
-10,700
-7% -$1.26M 3.44% 2
2021
Q3
$15.7M Sell
145,458
-6,520
-4% -$745K 3.13% 4
2021
Q2
$17.1M Sell
151,978
-34,200
-18% -$3.85M 3.35% 1
2021
Q1
$20.1M Buy
186,178
+400
+0.2% +$42.8K 3.2% 2
2020
Q4
$19.9M Sell
185,778
-100
-0.1% -$9.61K 3.33% 1
2020
Q3
$16.3M Sell
185,878
-14,230
-7% -$1.34M 3.25% 4
2020
Q2
$19.6M Sell
200,108
-457
-0.2% -$40.2K 3.82% 1
2020
Q1
$15.3M Sell
200,565
-9,800
-5% -$835K 3.48% 4
2019
Q4
$18.6M Buy
210,365
+39,430
+23% +$3.27M 2.94% 8
2019
Q3
$12.9M Sell
170,935
-1,620
-0.9% -$111K 2.06% 18
2019
Q2
$12.5M Buy
172,555
+38,400
+29% +$3.02M 2.01% 16
2019
Q1
$10.8M Sell
134,155
-10,820
-7% -$885K 1.74% 32
2018
Q4
$13.4M Sell
144,975
-9,200
-6% -$809K 2.17% 17
2018
Q3
$14.6M Buy
154,175
+43,500
+39% +$4.13M 1.89% 29
2018
Q2
$10.3M Sell
110,675
-1,200
-1% -$117K 1.38% 40
2018
Q1
$10.6M Sell
111,875
-14,550
-12% -$1.6M 1.44% 36
2017
Q4
$12.2M Sell
126,425
-15,700
-11% -$1.48M 1.7% 27
2017
Q3
$12.6M Sell
142,125
-1,200
-0.8% -$91.3K 1.81% 31
2017
Q2
$10.4M Sell
143,325
-164,520
-53% -$11.1M 1.57% 30
2017
Q1
$20.1M Sell
307,845
-40,100
-12% -$2.52M 2.67% 12
2016
Q4
$21.8M Sell
347,945
-10,830
-3% -$661K 2.56% 11
2016
Q3
$22.6M Sell
358,775
-67,400
-16% -$4.36M 2.53% 12
2016
Q2
$26.4M Sell
426,175
-5,220
-1% -$318K 2.58% 11
2016
Q1
$24.6M Sell
431,395
-6,700
-2% -$373K 2.48% 12
2015
Q4
$26M Buy
438,095
+41,300
+10% +$2.38M 2.63% 12
2015
Q3
$21.6M Sell
396,795
-11,300
-3% -$736K 1.85% 23
2015
Q2
$27.4M Sell
408,095
-28,200
-6% -$1.84M 2.14% 17
2015
Q1
$25.5M Sell
436,295
-110,400
-20% -$6.67M 1.99% 19
2014
Q4
$35.8M Buy
546,695
+6,200
+1% +$391K 2.75% 9
2014
Q3
$31.2M Sell
540,495
-66,000
-11% -$3.66M 2.59% 10
2014
Q2
$34.2M Sell
606,495
-1,600
-0.3% -$83.9K 3.04% 4
2014
Q1
$31.3M Buy
608,095
+90,100
+17% +$4.55M 2.91% 6
2013
Q4
$27.4M Sell
517,995
-28,400
-5% -$1.4M 3.19% 1
2013
Q3
$24.4M Buy
546,395
+44,200
+9% +$1.96M 2.96% 2
2013
Q2
$20.8M Buy
+502,195
New +$22M 2.45% 7

Other funds holding ABBV

SKBA Capital Management's ABBV Position: Q1 2026 in Review

SKBA Capital Management held its AbbVie (ABBV) position steady in Q1 2026 at 5,019 shares worth $1.09M. The position accounts for 0.15% of the portfolio, ranked #57.

SKBA Capital Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $35.8M in Q4 2014. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • SKBA Capital Management held 5,019 shares of AbbVie worth $1.09M as of Q1 2026.
  • SKBA Capital Management left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.15% of SKBA Capital Management's portfolio in Q1 2026, its #57 holding.
  • SKBA Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • SKBA Capital Management's AbbVie position peaked at $35.8M in Q4 2014.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on SKBA Capital Management's 13F filing for Q1 2026, filed 13 May 2026.